Document Detail

Evaluation of in vivo and in vitro quality of apheresis-collected RBC stored for 42 days.
MedLine Citation:
PMID:  9852409     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND OBJECTIVES: New technological developments make it possible to collect red blood cells (RBCs) by apheresis, which allows for better product consistency and has the potential for improved RBC quality. The purpose of these studies was to evaluate the quality and consistency of units of RBCs collected by apheresis using the MCS+(R) machine (Haemonetics Corp., Braintree, Mass., USA). MATERIALS AND METHODS: Two studies were performed. In study 1 (n = 10), using containers and CP2D/AS-3 solutions from Medsep Corp. (Covina, Calif. USA), one-unit apheresis RBCs were compared to manually collected RBCs in a random crossover design. In study 2 (n = 12), 6 subjects had one unit collected, while the remaining 6 subjects had two units of RBCs collected with comparison to previously manually collected RBCs from the same donors. Haemonetics containers and solutions were used in study 2. RESULTS: Low RBC volume variability was found for the apheresis collections with a standard deviation of only 6 ml difference between actual and target volumes. Combining the data from the two studies (n = 21 pairs), at 42 days of storage, the apheresis units showed slightly lower hemolysis (0.44+/-0.26 vs. 0.61+/-0.50%), lower supernatant potassium levels (50+/-3 vs. 53+/-3 mEq/l), and improved tolerance to osmotic shock (47+/-3 vs. 49+/-3%) as compared to manual units (p < 0.05). There was no statistically significant difference in RBC ATP (3.0+/-0.6 vs. 2.9+/-0.5 micromol/g Hb) or in 24-hour percent recoveries (81+/-6 for apheresis vs. 81+/-4% for apheresis red cells). Apheresis RBC quality was not affected by the manufacturer (Haemonetics vs. Medsep) of solutions and containers. CONCLUSIONS: RBC units collected by apheresis demonstrated low variability in volume of RBC mass collected, and showed similar RBC properties as compared to manually collected RBCs after processing and after 42 days of storage.
S Holme; M D Elfath; P Whitley
Related Documents :
10773929 - Efficacy of leucocyte filters during transfusions in preventing the development of anti...
21541359 - Congenital cytomegalovirus mortality in the united states, 1990-2006.
21501839 - Improving maternal mortality reporting at the community level with a 4-question modifie...
4069859 - Effects of neonatal polycythemia and partial exchange transfusion on cardiac function: ...
861319 - Role of respiration in effecting transfusion at cesarean section.
21159029 - Might asphyxia cause respiratory inhibition after crying in mature infants?
15607599 - Moderate hypothermia in neonatal encephalopathy: safety outcomes.
3344179 - Lack of adverse reactions to iron-fortified formula.
7074439 - Prevalence and duration of breast-feeding in manitoba.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Vox sanguinis     Volume:  75     ISSN:  0042-9007     ISO Abbreviation:  Vox Sang.     Publication Date:  1998  
Date Detail:
Created Date:  1999-02-23     Completed Date:  1999-02-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0413606     Medline TA:  Vox Sang     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  212-7     Citation Subset:  IM    
American Red Cross, Mid-Atlantic Region, Norfolk, VA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / pharmacology*
Blood Component Removal*
Blood Preservation*
Citrates / pharmacology*
Cross-Over Studies
Erythrocytes / cytology*,  drug effects
Glucose / pharmacology*
Hypertonic Solutions / pharmacology*
Middle Aged
Reg. No./Substance:
0/Anticoagulants; 0/Citrates; 0/Hypertonic Solutions; 50-99-7/Glucose; 51404-37-6/citrate phosphate dextrose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Erythrocytes and proinflammatory mediators in wound drainage.
Next Document:  Platelets stored in a new-generation container differences between plasma and platelet additive solu...